Nusinersen in Adult Patients with Spinal Muscular Atrophy
Neurol 95:e413-e416, Moshe-Lilie, O.,et al, 2020
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
NEJM 376:115-124, Powers, S.W.,et al, 2016
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Effect of Caudal Epidural Steroid or Saline Injection in Chronic Lumbar Radiculopathy: Multicentre, Blinded, Randomised Controlled Trial
BMJ 343:d5278,d5310, Iversen, T.,et al, 2011
Acupuncture for Chronic Low Back Pain
NEJM 363:454-461, Berman,B.M., et al, 2010
The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009
Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008
Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999
Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack
Arch Int Med 158:1013-1018, Cady,R.C.,et al, 1998
A Comparison of Divalproex with Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Arch Neurol 54:1141-1145, Kaniecki,R.G., 1997
Ethical Use of Placebos and Provocative Testing in Diagnosing Nonepileptic Seizures
Neurol 47:866-870, Devinsky,O.&Fisher,R., 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Utility and Reliability of Placebo Infusion in the Evaluation of Patients with Seizures
neurol 44:394-399, Walczak,T.S.,et al, 1994
Randomised Clinical Trial of Manipulative Therapy & PT for Persistent Back & Neck Complaints:1-Year Follow Up
BMJ 304:601-605, Koes,B.W.,et al, 1992
TENS for Chronic Low-Back Pain
Editorial, Lancet 337:462-4631991., , 1991
A Controlled Trial of Transcutaneous Electrical Nerve Stimulation (Tens) and Exercise for Chronic Low Back Pain
NEJM 322:1627-1634, Deyo,R.A.,et al, 1990
Dexamethasone is Not Superior to Placebo for Treating Lumbosacral Radicular Pain
Neurol 36:1593-1594, Haimovic,I.C.&Beresford,H.R., 1986
Controlled Comparison of Short-Wave Diathermy Treatment with Osteopathic Treatment in Non-specific Low Back Pain
Lancet 1:1258-1261, Gibons,T.,et al, 1985
Acupuncture Treatment of Chronic Back Pain, A Double-Blind Placebo-Controlled Trial
Am J Med 74:49-55, Mendelson,G.,et al, 1983
Pain II:New Approaches to Management
Ann Neurol 9:101-106, Fields,H.L., 1981
Biology of Placebo Analgesia
Am J Med 70:745-746, Fields,H.L.,et al, 1981
Analgesic Effects of Branding in Treatment of Headaches
BMJ 282:1576-1578, Branthwaite,A.,et al, 1981
The Chronic Pain Syndrome:Misconceptions & Management
Ann Int Med 93:588-596, Reuler,J.B.,et al, 1980
Opiate Peptides
Analgesia, & the Neuroendocrine System, Editorial, BMJ 1:741-742., , 1980
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Treatment for Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation, A Randomzid Clinical Trial
JAMA doi.10.1001/JAMA.2026.0076;2026, Aizer,A.A.,et al, 2026
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome
JAMA Neurol 83:250-258, Lim,T.R.et al, 2026
The 2024 McDonld Criteria for Dignosis of Multiple Sclerosis, The Rubber meets the Road
Neurol 106:e214688, Miller, A.E., 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
A 67-Year-Old Man with Exercise Intolerance nd Progressive Weakness
Neurol 106:e214830, Gosset,A.,et al, 2026
Left Atrial Appendage Closure - Another Overused Method in Cardiology?
NEJM 394:1336-1338, Widimsky,P, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Large Language Model Performance and Clinical Reasoning Tasks
JAMA Netw Open 9:e264003, Rao,A.S.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Neurol 106:e214864, Dhivagaran,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026